Breakthroughs and bottlenecks of psoriasis therapy: Emerging trends and advances in lipid based nano-drug delivery platforms for dermal and transdermal drug delivery
Authors:
- Siddharth SinghSSSiddharth Singh
- Rajendra AwasthiRARajendra Awasthi
- 12 May 2023
- journal article
- review article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 84
Abstract
No abstract availableKeywords
This publication has 248 references indexed in Scilit:
- Reduced CD18 Levels Drive Regulatory T Cell Conversion into Th17 Cells in the CD18hypo PL/J Mouse Model of PsoriasisThe Journal of Immunology, 2013
- Penetration and biological effects of topically applied cyclosporin A nanoparticles in a human skin organ culture inflammatory modelExperimental Dermatology, 2012
- Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging studyJournal of the European Academy of Dermatology and Venereology, 2012
- Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice SettingArchives of Dermatology, 2012
- Nanoemulsions versus microemulsions: terminology, differences, and similaritiesSoft Matter, 2011
- Applications of hydroxy acids: classification, mechanisms, and photoactivityClinical, Cosmetic and Investigational Dermatology, 2010
- The Risk of Depression, Anxiety, and Suicidality in Patients With PsoriasisArchives of Dermatology, 2010
- Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in miceJournal of Clinical Investigation, 2009
- Development and Validation of Human Psoriatic Skin EquivalentsThe American Journal of Pathology, 2008
- IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesisJournal of Experimental Medicine, 2006